Holen Sie sich die Stockscreener-App
1.93
3.98%
-0.08
Handel nachbörslich:
1.97
0.04
+2.07%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt FBIO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$2.01
Offen:
$1.95
24-Stunden-Volumen:
236.91K
Relative Volume:
1.17
Marktkapitalisierung:
$57.07M
Einnahmen:
$80.97M
Nettoeinkommen (Verlust:
$-78.31M
KGV:
-0.1741
EPS:
-11.0849
Netto-Cashflow:
$-129.56M
1W Leistung:
+2.66%
1M Leistung:
+2.12%
6M Leistung:
+9.66%
1J Leistung:
+5.46%
1-Tages-Spanne:
$1.90
$2.0299
1-Wochen-Bereich:
$1.81
$2.04
52-Wochen-Spanne:
$1.325
$2.36
Fortress Biotech Inc Stock (FBIO) Company Profile
Firmenname
Fortress Biotech Inc
Sektor
Branche
Telefon
781-652-4500
Adresse
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Vergleichen Sie FBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
1.93 | 59.44M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-15 | Fortgesetzt | ROTH MKM | Buy |
| 2022-08-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-10-02 | Eingeleitet | The Benchmark Company | Buy |
| 2019-12-18 | Eingeleitet | B. Riley FBR | Buy |
| 2018-02-28 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-07-11 | Eingeleitet | Rodman & Renshaw | Buy |
| 2017-03-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2016-10-03 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Fortress Biotech Inc Aktie (FBIO) Neueste Nachrichten
Fortress Biotech Inc. stock prediction for this weekJuly 2025 Reactions & Consistent Income Trade Recommendations - Newser
Multi asset correlation models including Fortress Biotech Inc.Portfolio Performance Report & Daily Volume Surge Trade Alerts - Newser
Fortress Biotech Inc.’s volatility index tracking explainedBond Market & Weekly Chart Analysis and Trade Guides - Newser
Visualizing Fortress Biotech Inc. stock with heatmapsTrade Performance Summary & Growth Focused Stock Pick Reports - Newser
Fortress Biotech Inc. stock trend outlook and recovery pathMarket Trend Summary & Growth Focused Entry Reports - Newser
Will Fortress Biotech Inc. price bounce be sustainableJuly 2025 Momentum & Accurate Trade Setup Notifications - Newser
Why Fortress Biotech Inc. stock attracts strong analyst attentionJuly 2025 Breakouts & Long Hold Capital Preservation Plans - Newser
Using Python tools to backtest Fortress Biotech Inc. strategies [Stock Surge]Trade Opportunity Analysis - Newser
How Fortress Biotech Inc. stock performs during market volatilityWeekly Profit Report & Verified Trade Idea Suggestions - Newser
Statistical indicators supporting Fortress Biotech Inc.’s strengthAI Generated Buy/Sell Signal Forecast - Newser
Key metrics from Fortress Biotech Inc.’s quarterly dataAI-Powered Stock Trend Movement Analysis - Newser
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire
Strategies to average down on Fortress Biotech Inc.Wealth Accumulation Outlook for Safe Investors - Newser
Chart based exit strategy for Fortress Biotech Inc.AI Screener for Daily Stock Forecast - Newser
Will Fortress Biotech Inc. rebound enough to break evenStrategy Playbook for Risk Controlled Trades - Newser
Should you hold or exit Fortress Biotech Inc. nowDaily Equity Signal Strength Summary Report - Newser
How high can Fortress Biotech Inc. stock goSmart Entry Watchlist with Daily Analysis - Newser
Multi factor analysis applied to Fortress Biotech Inc.Free Technical Entry Strategy for Beginners - Newser
Will Fortress Biotech Inc. stock split in the near futureTechnical Safety Zone Pattern Recognition - Newser
Key External Factors That Drive Fortress Biotech Inc. Stock Price MovementsRapid Trade Forecast Based on Indicators - Newser
Price action breakdown for Fortress Biotech Inc.Chart-Based Entry Confirmation for Beginners - Newser
Tools to assess Fortress Biotech Inc.’s risk profileSwing Trade Signal and Price Prediction - Newser
Fortress Biotech Inc. Ranks High in Smart Money TrackerRisk Controlled Picks With Real Returns Outlined - beatles.ru
Detecting price anomalies in Fortress Biotech Inc. with AIFuture Growth Stock Forecasting Strategy - Newser
How to build a dashboard for Fortress Biotech Inc. stockFree Access to Smart Investment Tips - Newser
Fortress Biotech (FBIO) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Using Python tools to backtest Fortress Biotech Inc. strategiesFundamental + Technical Combined Watchlist - Newser
Fortress Biotech Pref A FBIOP Q2 2025 Earnings Preview Upside Potential from Strategic Partnerships - AInvest
Fortress Biotech FBIO 2025Q2 Earnings Preview Upside Potential on Strategic Partnerships and Revenue Growth - AInvest
Combining price and volume data for Fortress Biotech Inc.Community Picked Stocks with Trade Insights - Newser
Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11 - GlobeNewswire
Envestnet Asset Management Inc. Buys 28,314 Shares of Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
Is Fortress Biotech Inc. a candidate for recovery playDaily Pick Forecast with Entry Zones - Newser
FORTRESS BIOTECH INC 9.375% CUM RED PER PREF SER A USD25.00 (FBIOP.US) will release its Earnings Reports after the market closes on August 12th. - 富途牛牛
Finanzdaten der Fortress Biotech Inc-Aktie (FBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):